Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHOD FOR TREATING TUMORS BY MEANS OF COMBINING EXOGENOUS ANTIGEN WITH THERAPEUTIC AGENT
Document Type and Number:
WIPO Patent Application WO/2023/124973
Kind Code:
A1
Abstract:
Disclosed in the present invention is a method for treating tumors by means of combining an exogenous antigen with a therapeutic agent, which belongs to the technical field of gene therapy. Disclosed in present invention is a composition, which contains an exogenous antigen and a therapeutic agent, wherein the therapeutic agent kills a tissue or a cell containing the exogenous antigen by means of taking the exogenous antigen as a target, and does not act on a tissue or a cell free of the exogenous antigen, thereby specifically killing the tissue or the cell, such as a tumor cell. On the basis that the exogenous antigen can be expressed in different types of tumors in different individuals, the method of the present invention is a broad-spectrum anti-tumor method.

Inventors:
ZHOU CHAO (CN)
AN HONG (CN)
ZHOU LING (CN)
DU YONGBIAO (CN)
LIAO PENGYUN (CN)
WANG TAOXI (CN)
YIN HAIBIN MICHAEL (CN)
Application Number:
PCT/CN2022/138691
Publication Date:
July 06, 2023
Filing Date:
December 13, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GUANGZHOU ANJIE BIOMEDICAL TECH CO LTD (CN)
International Classes:
A61K45/00; A61P35/00; C12N7/01; C12N15/867
Foreign References:
CN114344472A2022-04-15
CN110856724A2020-03-03
US20210077554A12021-03-18
CN110856751A2020-03-03
Other References:
WING ANNA, FAJARDO CARLOS ALBERTO, POSEY, SHAW CAROLYN, DA TONG, YOUNG REGINA M, ALEMANY RAMON, JUNE CARL H, GUEDAN SONIA: "Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus–Driven Production of a Bispecific T-cell Engager", CANCER IMMUNOLOGY RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 6, no. 5, 1 May 2018 (2018-05-01), US , pages 605 - 616, XP009517684, ISSN: 2326-6066, DOI: 10.1158/2326-6066.CIR-17-0314
HOFFMANN DENNIS, GRUNWALD THOMAS, KUATE SERAPHIN, WILDNER OLIVER: "Mechanistic analysis and comparison of viral fusogenic membrane proteins for their synergistic effects on chemotherapy", CANCER BIOLOGY & THERAPY, LANDES BIOSCIENCE, US, vol. 6, no. 4, 10 April 2007 (2007-04-10), US , pages 510 - 518, XP093074774, ISSN: 1538-4047, DOI: 10.4161/cbt.6.4.3815
ROSEWELL SHAW AMANDA, PORTER CAROLINE E., YIP TIFFANY, MAH WAY-CHAMP, MCKENNA MARY K., DYSTHE MATTHEW, JUNG YOUNGROCK, PARIHAR ROB: "Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors", COMMUNICATIONS BIOLOGY, vol. 4, no. 1, XP093074777, DOI: 10.1038/s42003-021-01914-8
KIYONORI TANOUE, AMANDA ROSEWELL SHAW, NORIHIRO WATANABE, CAROLINE PORTER, BHAKTI RANA, STEPHEN GOTTSCHALK, MALCOLM BRENNER, MASAT: "Armed Oncolytic Adenovirus–Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 77, no. 8, 15 April 2017 (2017-04-15), US, pages 2040 - 2051, XP055384740, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-16-1577
Attorney, Agent or Firm:
JIAQUAN IP LAW (CN)
Download PDF: